The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsudaira, P. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61070-1 · Cited by 4,950
Cyclophilin: A Specific Cytosolic Binding Protein for Cyclosporin A
Handschumacher, R. E., Harding, M. W., Rice, J., Drugge, R. J., & Speicher, D. W. (1984) · Science · doi:10.1126/science.6238408 · Cited by 1,673
Self-citationCyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins
Fischer, G., Wittmann-Liebold, B., Lang, K., Kiefhaber, T., & Schmid, F. X. (1989) · Nature · doi:10.1038/337476a0 · Cited by 1,407
KINO, T., HATANAKA, H., HASHIMOTO, M., NISHIYAMA, M., GOTO, T., OKUHARA, M., KOHSAKA, M., AOKI, H., & IMANAKA, H. (1987) · The Journal of Antibiotics · doi:10.7164/antibiotics.40.1249 · Cited by 1,241
Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin
Takahashi, N., Hayano, T., & Suzuki, M. (1989) · Nature · doi:10.1038/337473a0 · Cited by 1,078
Structure of FK506, a novel immunosuppressant isolated from Streptomyces
Tanaka, H., Kuroda, A., Marusawa, H., Hatanaka, H., Kino, T., Goto, T., Hashimoto, M., & Taga, T. (1987) · Journal of the American Chemical Society · doi:10.1021/ja00250a050 · Cited by 512
Inhibition of the immune response by rapamycin, a new antifungal antibiotic
Martel, R. R., Klicius, J., & Galet, S. (1977) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y77-007 · Cited by 463
Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation.
Sawada, S., Suzuki, G., Kawase, Y., & Takaku, F. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.6.1797 · Cited by 413
Isolation and amino acid sequence of cyclophilin.
Harding, M. W., Handschumacher, R. E., & Speicher, D. W. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83945-5 · Cited by 293
Self-citationShieh, B.-H., Stamnes, M. A., Seavello, S., Harris, G. L., & Zuker, C. S. (1989) · Nature · doi:10.1038/338067a0 · Cited by 278
Research works printed but not linked: 7
- Yoshimura, N., Matsui, S., Hamashima, T. & Oka, T. Transplantation 47, 351–356 (1989). · doi:10.1097/00007890-198902000-00034
- Sanghvi, A. et al. Transplant. Proc. 19 (Suppl. 6) 45 (1987).
- Second International Congress on Cyclosporine. Transplant. Proc. 20, Suppl. 2 (1988).
- Warti, V. et al. Transplantation 46, 453–455 (1988). · doi:10.1097/00007890-198809000-00025
- Coleman, R. S. & Danishefsky, S. J. Heterocycles 28, 157–161 (1989). · doi:10.3987/com-88-s70
- Bayley, H., Standring, D. & Knowles, J. R. Tetrahedron Lett. 39, 3633–3634 (1978). · doi:10.1016/s0040-4039(01)95015-4
- Gershoni, J. M., Davis, F. E. & Palade, G. E. Analyt. Biochem. 144, 32–40 (1085). · doi:10.1016/0003-2697(85)90080-6
Cited by
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
Liu, J., Farmer, J. D., Lane, W. S., Friedman, J., Weissman, I., & Schreiber, S. L. (1991) · Cell · doi:10.1016/0092-8674(91)90124-h · Cited by 4,116
Self-citationThe mechanism of action of cyclosporin A and FK506
Schreiber, S. L., & Crabtree, G. R. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90111-j · Cited by 2,127
Self-citationTargets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast
Heitman, J., Movva, N. R., & Hall, M. N. (1991) · Science · doi:10.1126/science.1715094 · Cited by 2,006
Regulation of translation initiation by FRAP/mTOR
Gingras, A.-C., Raught, B., & Sonenberg, N. (2001) · Genes & Development · doi:10.1101/gad.887201 · Cited by 1,545
Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P., & Snyder, S. H. (1994) · Cell · doi:10.1016/0092-8674(94)90570-3 · Cited by 1,509
Chemistry and Biology of the Immunophilins and Their Immunosuppressive Ligands
Schreiber, S. L. (1991) · Science · doi:10.1126/science.1702904 · Cited by 1,494
Self-citationCalcineurin Inhibitor Nephrotoxicity
Naesens, M., Kuypers, D. R. J., & Sarwal, M. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04800908 · Cited by 1,489
Fingar, D. C., & Blenis, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207542 · Cited by 1,247
Chung, J., Kuo, C. J., Crabtree, G. R., & Blenis, J. (1992) · Cell · doi:10.1016/0092-8674(92)90643-q · Cited by 1,150
Target identification and mechanism of action in chemical biology and drug discovery
Schenone, M., Dančík, V., Wagner, B. K., & Clemons, P. A. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1199 · Cited by 1,096
Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A
Flanagan, W. M., Corthésy, B., Bram, R. J., & Crabtree, G. R. (1991) · Nature · doi:10.1038/352803a0 · Cited by 1,056
Identification of a protein required for disulfide bond formation in vivo
Bardwell, J. C. A., McGovern, K., & Beckwith, J. (1991) · Cell · doi:10.1016/0092-8674(91)90532-4 · Cited by 979
Calcium Absorption Across Epithelia
Hoenderop, J. G. J., Nilius, B., & Bindels, R. J. M. (2005) · Physiological Reviews · doi:10.1152/physrev.00003.2004 · Cited by 936
Structure of the FKBP12-Rapamycin Complex Interacting with Binding Domain of Human FRAP
Choi, J., Chen, J., Schreiber, S. L., & Clardy, J. (1996) · Science · doi:10.1126/science.273.5272.239 · Cited by 929
Self-citationMicroarrays of cells expressing defined cDNAs
Ziauddin, J., & Sabatini, D. M. (2001) · Nature · doi:10.1038/35075114 · Cited by 922
Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design
Babine, R. E., & Bender, S. L. (1997) · Chemical Reviews · doi:10.1021/cr960370z · Cited by 892
Regulation of Immune Responses by mTOR
Powell, J. D., Pollizzi, K. N., Heikamp, E. B., & Horton, M. R. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075024 · Cited by 836
Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein
Brillantes, A.-M. B., Ondrias, K., Scott, A., Kobrinsky, E., Ondriašová, E., Moschella, M. C., Jayaraman, T., Landers, M., Ehrlich, B. E., & Marks, A. R. (1994) · Cell · doi:10.1016/0092-8674(94)90214-3 · Cited by 827
FKBP51 Affects Cancer Cell Response to Chemotherapy by Negatively Regulating Akt
Pei, H., Li, L., Fridley, B. L., Jenkins, G. D., Kalari, K. R., Lingle, W., Petersen, G., Lou, Z., & Wang, L. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.07.016 · Cited by 709
Bierer, B. E., Mattila, P. S., Standaert, R. F., Herzenberg, L. A., Burakoff, S. J., Crabtree, G., & Schreiber, S. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9231 · Cited by 696
Self-citationRapamycin-Induced Inhibition of the 70-Kilodalton S6 Protein Kinase
Price, D. J., Grove, J. R., Calvo, V., Avruch, J., & Bierer, B. E. (1992) · Science · doi:10.1126/science.1380182 · Cited by 666
Sehgal, S. N. (1998) · Clinical Biochemistry · doi:10.1016/s0009-9120(98)00045-9 · Cited by 663
Splicing factor SF3b as a target of the antitumor natural product pladienolide
Kotake, Y., Sagane, K., Owa, T., Mimori-Kiyosue, Y., Shimizu, H., Uesugi, M., Ishihama, Y., Iwata, M., & Mizui, Y. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.16 · Cited by 657
IMMUNOPHARMACOLOGY OF RAPAMYCIN
Abraham, R. T., & Wiederrecht, G. J. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.483 · Cited by 653
Prolyl cis-trans isomerization as a molecular timer
Lu, K. P., Finn, G., Lee, T. H., & Nicholson, L. K. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.35 · Cited by 652
Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts
G�thel, S. F., & Marahiel, M. A. (1999) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180050299 · Cited by 647
Atomic Structure of FKBP-FK506, an Immunophilin-Immunosuppressant Complex
Van Duyne, G. D., Standaert, R. F., Karplus, P. A., Schreiber, S. L., & Clardy, J. (1991) · Science · doi:10.1126/science.1709302 · Cited by 635
Self-citationCharacterization of the FKBP·Rapamycin·FRB Ternary Complex
Banaszynski, L. A., Liu, C. W., & Wandless, T. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja043277y · Cited by 609
The target of rapamycin (TOR) proteins
Raught, B., Gingras, A.-C., & Sonenberg, N. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121145898 · Cited by 605
Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase
Kuo, C. J., Chung, J., Fiorentino, D. F., Flanagan, W. M., Blenis, J., & Crabtree, G. R. (1992) · Nature · doi:10.1038/358070a0 · Cited by 595
Target profiling of small molecules by chemical proteomics
Rix, U., & Superti-Furga, G. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.216 · Cited by 575
Liu, J., Albers, M. W., Wandless, T. J., Luan, S., Alberg, D. G., Belshaw, P. J., Cohen, P., MacKintosh, C., Klee, C. B., & Schreiber, S. L. (1992) · Biochemistry · doi:10.1021/bi00131a002 · Cited by 558
Self-citationProline-Dependent Structural and Biological Properties of Peptides and Proteins
Yaron, A., Naider, F., & Scharpe, S. (1993) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239309082572 · Cited by 551
Yang, Q., & Guan, K.-L. (2007) · Cell Research · doi:10.1038/cr.2007.64 · Cited by 535
Creighton, T. E. (1990) · Biochemical Journal · doi:10.1042/bj2700001 · Cited by 515
Kofron, J. L., Kuzmic, P., Kishore, V., Colon-Bonilla, E., & Rich, D. H. (1991) · Biochemistry · doi:10.1021/bi00239a007 · Cited by 507
Chemical Genetic Control of Protein Levels: Selective in Vivo Targeted Degradation
Schneekloth, J. S., Fonseca, F. N., Koldobskiy, M., Mandal, A., Deshaies, R., Sakamoto, K., & Crews, C. M. (2004) · Journal of the American Chemical Society · doi:10.1021/ja039025z · Cited by 487
Nicolli, A., Basso, E., Petronilli, V., Wenger, R. M., & Bernardi, P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.4.2185 · Cited by 479
Cameron, A. M., Steiner, J. P., Roskams, A. J., Ali, S. M., Ronnettt, G. V., & Snyder, S. H. (1995) · Cell · doi:10.1016/0092-8674(95)90124-8 · Cited by 476
Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia
Sharkey, J., & Butcher, S. P. (1994) · Nature · doi:10.1038/371336a0 · Cited by 455
Target deconvolution strategies in drug discovery
Terstappen, G. C., Schlüpen, C., Raggiaschi, R., & Gaviraghi, G. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2410 · Cited by 429
Chemical genetics resulting from a passion for synthetic organic chemistry
Schreiber, S. L. (1998) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(98)00126-6 · Cited by 410
Self-citationFriedman, J., & Weissman, I. (1991) · Cell · doi:10.1016/0092-8674(91)90123-g · Cited by 395
The Immunophilin FKBP12 Functions as a Common Inhibitor of the TGFβ Family Type I Receptors
Wang, T., Li, B.-Y., Danielson, P. D., Shah, P. C., Rockwell, S., Lechleider, R. J., Martin, J., Manganaro, T., & Donahoe, P. K. (1996) · Cell · doi:10.1016/s0092-8674(00)80116-6 · Cited by 388
FK506 and cyclosporin, molecular probes for studying intracellular signal transduction
Liu, J. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90048-p · Cited by 383
Click Chemistry in Proteomic Investigations
Parker, C. G., & Pratt, M. R. (2020) · Cell · doi:10.1016/j.cell.2020.01.025 · Cited by 380
Mechanism of TGFβ receptor inhibition by FKBP12
Chen, Y.-G., Liu, F., & Massagué, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3866 · Cited by 363
Mechanism of action of the immunosuppressant rapamycin
Dumont, F. J., & Su, Q. (1995) · Life Sciences · doi:10.1016/0024-3205(95)02233-3 · Cited by 358
Peters, D. H., Fitton, A., Plosker, G. L., & Faulds, D. (1993) · Drugs · doi:10.2165/00003495-199346040-00009 · Cited by 356
Probing Immunosuppressant Action with a Nonnatural Immunophilin Ligand
Bierer, B. E., Somers, P. K., Wandless, T. J., Burakoff, S. J., & Schreiber, S. L. (1990) · Science · doi:10.1126/science.1700475 · Cited by 352
Self-citationThe Mechanism of Action of FK‐506 and Cyclosporin A
WIEDERRECHT, G., LAM, E., HUNG, S., MARTIN, M., & SIGAL, N. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb17137.x · Cited by 350
The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes.
Mattila, P. S., Ullman, K. S., Fiering, S., Emmel, E. A., McCutcheon, M., Crabtree, G. R., & Herzenberg, L. A. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07893.x · Cited by 349
Phenotypic drug discovery: recent successes, lessons learned and new directions
Vincent, F., Nueda, A., Lee, J., Schenone, M., Prunotto, M., & Mercola, M. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00472-w · Cited by 348
High brain densities of the immunophilin FKBP colocalized with calcineurin
Steiner, J. P., Dawson, T. M., Fotuhi, M., Glatt, C. E., Snowman, A. M., Cohen, N., & Snyder, S. H. (1992) · Nature · doi:10.1038/358584a0 · Cited by 345
Architecture of human mTOR complex 1
Aylett, C. H. S., Sauer, E., Imseng, S., Boehringer, D., Hall, M. N., Ban, N., & Maier, T. (2016) · Science · doi:10.1126/science.aaa3870 · Cited by 344
Peptidylproline cis‐trans‐isomerases: immunophilins
GALAT, A. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18189.x · Cited by 343
Self-citationThe emerging role of mass spectrometry-based proteomics in drug discovery
Meissner, F., Geddes-McAlister, J., Mann, M., & Bantscheff, M. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00409-3 · Cited by 341
Steiner, J. P., Connolly, M. A., Valentine, H. L., Hamilton, G. S., Dawson, T. M., Hester, L., & Snyder, S. H. (1997) · Nature Medicine · doi:10.1038/nm0497-421 · Cited by 341
Mahfouz, M. M., Kim, S., Delauney, A. J., & Verma, D. P. S. (2006) · The Plant Cell · doi:10.1105/tpc.105.035931 · Cited by 337
Steiner, J. P., Hamilton, G. S., Ross, D. T., Valentine, H. L., Guo, H., Connolly, M. A., Liang, S., Ramsey, C., Li, J.-H. J., Huang, W., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.2019 · Cited by 327
FKBP Family Proteins: Immunophilins with Versatile Biological Functions
Kang, C. B., Hong, Y., Dhe-Paganon, S., & Yoon, H. S. (2008) · Neurosignals · doi:10.1159/000123041 · Cited by 327
Parallel Chemical Genetic and Genome-Wide RNAi Screens Identify Cytokinesis Inhibitors and Targets
Eggert, U. S., Kiger, A. A., Richter, C., Perlman, Z. E., Perrimon, N., Mitchison, T. J., & Field, C. M. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020379 · Cited by 325
Price, E. R., Zydowsky, L. D., Jin, M. J., Baker, C. H., McKeon, F. D., & Walsh, C. T. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1903 · Cited by 314
Molecular cloning and overexpression of the human FK506-binding protein FKBP
Standaert, R. F., Galat, A., Verdine, G. L., & Schreiber, S. L. (1990) · Nature · doi:10.1038/346671a0 · Cited by 312
Self-citationCafferkey, R., Young, P. R., McLaughlin, M. M., Bergsma, D. J., Koltin, Y., Sathe, G. M., Faucette, L., Eng, W. K., Johnson, R. K., & Livi, G. P. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6012 · Cited by 309
Peptidyl‐Prolyl cis/trans Isomerases and Their Effectors
Fischer, G. (1994) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199414151 · Cited by 308
Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway
Nataraj, C., Oliverio, M. I., Mannon, R. B., Mannon, P. J., Audoly, L. P., Amuchastegui, C. S., Ruiz, P., Smithies, O., & Coffman, T. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7451 · Cited by 308
Identifying the proteins to which small-molecule probes and drugs bind in cells
Ong, S.-E., Schenone, M., Margolin, A. A., Li, X., Do, K., Doud, M. K., Mani, D. R., Kuai, L., Wang, X., Wood, J. L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900191106 · Cited by 304
Self-citationAssociation of a 59-kilodalton immunophilin with the glucocorticoid receptor complex
Tai, P.-K. K., Albers, M. W., Chang, H., Faber, L. E., & Schreiber, S. L. (1992) · Science · doi:10.1126/science.1376003 · Cited by 304
Self-citationSolution Structure of FKBP, a Rotamase Enzyme and Receptor for FK506 and Rapamycin
Michnick, S. W., Rosen, M. K., Wandless, T. J., Karplus, M., & Schreiber, S. L. (1991) · Science · doi:10.1126/science.1709301 · Cited by 301
Self-citationIdentification of Direct Protein Targets of Small Molecules
Lomenick, B., Olsen, R. W., & Huang, J. (2011) · ACS Chemical Biology · doi:10.1021/cb100294v · Cited by 299
A three-hybrid system for detecting small ligand–protein receptor interactions
Licitra, E. J., & Liu, J. O. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.12817 · Cited by 299
Harrison, R. K., & Stein, R. L. (1990) · Biochemistry · doi:10.1021/bi00468a001 · Cited by 299
Walsh, D. P., & Chang, Y.-T. (2006) · Chemical Reviews · doi:10.1021/cr0404141 · Cited by 296
Heitman, J., Movva, N. R., Hiestand, P. C., & Hall, M. N. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1948 · Cited by 294
Zydowsky, L. D., Etzkorn, F. A., Chang, H. Y., Ferguson, S. B., Stolz, L. A., Ho, S. I., & Walsh, C. T. (1992) · Protein Science · doi:10.1002/pro.5560010903 · Cited by 292
Walsh, C. T., Zydowsky, L. D., & McKeon, F. D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42176-x · Cited by 275
Goul, C., Peruzzo, R., & Zoncu, R. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00641-8 · Cited by 269
Prolyl Isomerases: Role in Protein Folding
Schmid, F. X., Mayr, L. M., Mucke, M., & Schonbrunner, E. R. (1993) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60563-x · Cited by 267
Physiologic Functions of Cyclophilin D and the Mitochondrial Permeability Transition Pore
Elrod, J. W., & Molkentin, J. D. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0321 · Cited by 266
Stamnes, M. A., Shieh, B.-H., Chuman, L., Harris, G. L., & Zuker, C. S. (1991) · Cell · doi:10.1016/0092-8674(91)90156-s · Cited by 263
Chen, X., Wang, Y., Ma, N., Tian, J., Shao, Y., Zhu, B., Wong, Y. K., Liang, Z., Zou, C., & Wang, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0186-y · Cited by 263
Sinars, C. R., Cheung-Flynn, J., Rimerman, R. A., Scammell, J. G., Smith, D. F., & Clardy, J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0231020100 · Cited by 254
Rapamycins: Antifungal, antitumor, antiproliferative, and immunosuppressive macrolides
Morris, R. E. (1992) · Transplantation Reviews · doi:10.1016/s0955-470x(10)80014-x · Cited by 253
Dumont, F. J., Staruch, M. J., Koprak, S. L., Siekierka, J. J., Lin, C. S., Harrison, R., Sewell, T., Kindt, V. M., Beattie, T. R., & Wyvratt, M. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.3.751 · Cited by 250
Calcineurin: Structure, function, and inhibition
Hemenway, C. S., & Heitman, J. (1999) · Cell Biochemistry and Biophysics · doi:10.1007/bf02737887 · Cited by 227
Winbanks, C. E., Weeks, K. L., Thomson, R. E., Sepulveda, P. V., Beyer, C., Qian, H., Chen, J. L., Allen, J. M., Lancaster, G. I., Febbraio, M. A., et al. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201109091 · Cited by 218
How Chemoproteomics Can Enable Drug Discovery and Development
Moellering, R. E., & Cravatt, B. F. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.01.001 · Cited by 182
FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition
Baughman, G., Wiederrecht, G. J., Campbell, N. F., Martin, M. M., & Bourgeois, S. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4395 · Cited by 173
FKBP Ligands—Where We Are and Where to Go?
Kolos, J. M., Voll, A. M., Bauder, M., & Hausch, F. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01425 · Cited by 158
“6 FKBP12 was first described in 1989 by Harding et al. (1989) and Siekierka et al. (1989).”
BackgroundRefined structure of the FKBP12–rapamycin–FRB ternary complex at 2.2 Å resolution
Liang, J., Choi, J., & Clardy, J. (1999) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998014747 · Cited by 148
Calcineurin is essential in cyclosporin A- and FK506-sensitive yeast strains.
Breuder, T., Hemenway, C. S., Movva, N. R., Cardenas, M. E., & Heitman, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5372 · Cited by 135
Chemoproteomics and Chemical Probes for Target Discovery
Drewes, G., & Knapp, S. (2018) · Trends in Biotechnology · doi:10.1016/j.tibtech.2018.06.008 · Cited by 132
Rapamycin-inspired macrocycles with new target specificity
Guo, Z., Hong, S. Y., Wang, J., Rehan, S., Liu, W., Peng, H., Das, M., Li, W., Bhat, S., Peiffer, B., et al. (2019) · Nature Chemistry · doi:10.1038/s41557-018-0187-4 · Cited by 120
Wiederrecht, G., Hung, S., Chan, H. K., Marcy, A., Martin, M., Calaycay, J., Boulton, D., Sigal, N., Kincaid, R. L., & Siekierka, J. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36676-1 · Cited by 115
Periyasamy, S., Hinds, T., Shemshedini, L., Shou, W., & Sanchez, E. R. (2010) · Oncogene · doi:10.1038/onc.2009.458 · Cited by 108
“In the previous study, we also showed that FK506 inhibition of AR activity was not mediated by classical immunophilins such as FKBP12, but our results did not discriminate between FKBP51 and FKBP52.”
BackgroundInfluentialCereblon modulators: Low molecular weight inducers of protein degradation
Chamberlain, P. P., & Cathers, B. E. (2019) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2019.02.004 · Cited by 106
CRISPR Approaches to Small Molecule Target Identification
Jost, M., & Weissman, J. S. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.7b00965 · Cited by 88
Periyasamy, S., Warrier, M., Tillekeratne, M. P. M., Shou, W., & Sanchez, E. R. (2007) · Endocrinology · doi:10.1210/en.2007-0145 · Cited by 78
Burnett, G. L., Yang, Y. C., Aggen, J. B., Pitzen, J., Gliedt, M. K., Semko, C. M., Marquez, A., Evans, J. W., Wang, G., Won, W. S., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01658 · Cited by 72
Metadata
- Authors
- Harding, M. W., Galat, A., Uehling, D. E., & Schreiber, S. L.
- Venue
- Nature
- Published
- 1989-10
- Volume
- 341
- Issue
- 6244
- Pages
- 758-760
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1978879981
- Cited by
- 1,396
- References
- 16
- FWCI
- 29.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.